319 related articles for article (PubMed ID: 26159281)
1. Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis.
Boettler T; Thimme R
Dig Dis; 2015; 33(4):608-12. PubMed ID: 26159281
[TBL] [Abstract][Full Text] [Related]
2. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
[TBL] [Abstract][Full Text] [Related]
3. [Management and treatment of patients with hepatitis B].
den Eynde EV; Riveiro-Barciela M
Enferm Infecc Microbiol Clin; 2016 Jul; 34 Suppl 3():47-51. PubMed ID: 27474247
[TBL] [Abstract][Full Text] [Related]
4. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
Viganò M; Invernizzi F; Lampertico P
Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs).
Grossi G; Viganò M; Loglio A; Lampertico P
Liver Int; 2017 Jan; 37 Suppl 1():45-51. PubMed ID: 28052621
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
Buster EH; Janssen HL
Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
[TBL] [Abstract][Full Text] [Related]
7. Impact of HBV therapy on the incidence of hepatocellular carcinoma.
Triolo M; Della Corte C; Colombo M
Liver Int; 2014 Feb; 34 Suppl 1():139-45. PubMed ID: 24373091
[TBL] [Abstract][Full Text] [Related]
8. Impact of therapy on the outcome of chronic hepatitis B.
Liaw YF
Liver Int; 2013 Feb; 33 Suppl 1():111-5. PubMed ID: 23286854
[TBL] [Abstract][Full Text] [Related]
9. Review article: current antiviral therapy of chronic hepatitis B.
Ayoub WS; Keeffe EB
Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
[TBL] [Abstract][Full Text] [Related]
11. HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
Viganò M; Mangia G; Lampertico P
Liver Int; 2014 Feb; 34 Suppl 1():120-6. PubMed ID: 24373088
[TBL] [Abstract][Full Text] [Related]
12. [Chronic hepatitis B: current therapy].
Buffet C
Bull Acad Natl Med; 2008 Nov; 192(8):1625-37; discussion 1638-9. PubMed ID: 19445377
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Okada M; Enomoto M; Kawada N; Nguyen MH
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma.
Kim JH; Sinn DH; Kim K; Kim H; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Gut Liver; 2016 Nov; 10(6):939-947. PubMed ID: 27282264
[TBL] [Abstract][Full Text] [Related]
15. [Treatment has a positive impact on the long-term evolution of chronic hepatitis B].
Marcellin P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S99-102. PubMed ID: 21095519
[No Abstract] [Full Text] [Related]
16. Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines.
Colle I; Adler M; Brenard R; Henrion J; Langlet P; Michielsen P; Orlent H; Reynaert H; Sprengers D; Stärkel P; Van Damme P; Verslype C; Delwaide J;
Acta Gastroenterol Belg; 2007; 70(4):389-420. PubMed ID: 18330099
[No Abstract] [Full Text] [Related]
17. Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
Park YH; Kim BK; Kim JK; Kim HC; Kim DY; Park JY; Han KH; Kim SU; Shin SH; Hahn KY; Ahn SH
J Gastroenterol Hepatol; 2014 May; 29(5):1005-11. PubMed ID: 24325579
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy of chronic hepatitis B.
van Bömmel F; Berg T
Intervirology; 2014; 57(3-4):171-80. PubMed ID: 25034485
[TBL] [Abstract][Full Text] [Related]
20. Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis.
Goyal SK; Dixit VK; Shukla SK; Ghosh J; Behera M; Tripathi M; Gupta N; Ranjan A; Jain AK
Indian J Gastroenterol; 2015 Jul; 34(4):286-91. PubMed ID: 26243587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]